Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
about
Clinician identification of youth abusing over-the-counter products for weight control in a large U.S. integrated health system.Sodium-bicarbonate cotransporter NBCn1 in the kidney medullary thick ascending limb cell line is upregulated under acidic conditions and enhances ammonium transport.The role of the renal ammonia transporter Rhcg in metabolic responses to dietary proteinLow serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) StudyConsequences and therapy of the metabolic acidosis of chronic kidney disease.Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients.High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients.Sabiporide improves cardiovascular function, decreases the inflammatory response and reduces mortality in acute metabolic acidosis in pigs.HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury.Effect of bicarbonate supplementation on renal function and nutritional indices in predialysis advanced chronic kidney disease.Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis.A low serum bicarbonate concentration as a risk factor for mortality in peritoneal dialysis patients.Sodium-bicarbonate cotransporter NBCn1/Slc4a7 inhibits NH4Cl-mediated inward current in Xenopus oocytes.Renal tubular acidosis is highly prevalent in critically ill patientsDoes oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adultsSerum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.Low Serum Bicarbonate Predicts Residual Renal Function Loss in Peritoneal Dialysis PatientsShort- and long-term effects of alkali therapy in chronic kidney disease: a systematic reviewDietary acid load: a novel nutritional target in chronic kidney disease?Effects of oral sodium bicarbonate in patients with CKDMetabolic acidosis treatment as part of a strategy to curb inflammation.Timing of onset of CKD-related metabolic complicationsEffect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study.Plasma bicarbonate and odds of incident hypertension.Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD.Bicarbonate supplementation slows progression of CKD and improves nutritional status.Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.Metabolic acidosis in maintenance hemodialysis patients: clinical impact and intervention.1H NMR-based metabolite profiling of plasma in a rat model of chronic kidney disease.Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans.Treatment of metabolic acidosis in patients with CKD.Multi-Trajectory Models of Chronic Kidney Disease ProgressionProtein Nutrition and Malnutrition in CKD and ESRD.Differential diagnosis of nongap metabolic acidosis: value of a systematic approach.Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?New therapeutic strategies under development to halt the progression of renal failure.The use and interpretation of serum bicarbonate concentration in dialysis patients.
P2860
Q33846099-89D9C810-195F-4F04-A133-106E1D0C29AAQ34071835-D8518856-F7A6-49BD-8975-6E49CDEE1AD2Q34103394-853DC190-FF67-48F3-9927-EC79D611B7C5Q34254449-E26DEC48-B046-4A8D-B7AF-00F3242B00E0Q34254623-47552D2C-7D70-4A24-9F87-3A24371D4AF0Q34347210-BD0BA012-23B5-4055-AF77-70E90598EB20Q34405366-2458E7E1-CB32-47AB-9C1F-BC38E16D833DQ34539337-C7A9417E-E1B3-45F3-B362-73CDBF509D6BQ34551966-8D157DA1-552D-4938-81E5-B2BCB73CED77Q34801048-DDBAA02A-D6B6-4314-96B5-3AA5495A89EFQ34980247-F05AE50D-AA94-4D69-9B70-A5FE4DCDE775Q35002376-7A72BDD4-8A6F-47D6-8A8B-C57B6004F06BQ35070638-9493DECC-795F-42F9-A224-1704B94AD4A4Q35126921-EA97B919-29E8-490A-838C-17DF909520F8Q35505169-C4BE4089-DD26-40CA-AD10-4CDE6AEF6277Q35908286-CEA22228-3C25-4317-8AB4-49E3239C04E0Q35922978-84ADAAB4-F8E8-4195-A88E-A5F4CF629CD2Q35985823-596C315B-930C-41A4-BD97-A204BFDBE3F7Q36194634-4FA0EB73-E9FB-43DB-B490-020E75A66908Q36632184-B9737CDC-A1F2-4D04-940E-5902E6E4BED0Q36706346-E5D3328E-CC0C-4051-A5C1-9B244EB6B076Q36810485-475E1B50-04DF-4F18-A917-D83532D7A4F2Q36948547-AC4586EB-1C11-4025-ACF2-4F176B8143AFQ37042178-A536A915-A9D4-48CF-B30D-E5B7F9F4F37BQ37060053-3044296A-FC08-48D3-82F2-61D1F72D58C3Q37075325-DB204792-6D08-450A-90D9-814A48EB4C4FQ37277228-C881DEFF-F438-43B3-93DA-23B9A95AA186Q37290778-8EDD263E-D1E0-430C-A203-461ADB026F80Q37330555-6A86EB70-B2C8-4FD7-B275-C9BC793F535FQ37405600-FD555DC7-4945-4C83-A6D3-2FBF57D2F05AQ37489077-8C93CCFD-EB15-4CAE-816C-B890DD9EDCEFQ37495723-316E20C1-A797-4337-9A4D-F34EBC943507Q37590515-BC49DD92-B8B4-432A-A040-408005DFEE04Q37625304-32CDD0F0-0C0B-4B70-861C-56FDF587668FQ37676482-F91E0853-1213-40B7-BC93-B2169F957301Q37729646-2E68CB1B-DDF9-4369-918F-8F5F8628161BQ37992035-429BB695-3A2A-48B1-82D8-7855068FF8B6Q38031214-D392117D-82E9-4CCA-AD60-AD0ECA137712Q38201504-CD19246F-E61C-47F2-8144-1C92E1D01DF9Q38226311-A21A627F-6838-4BDD-B14B-F55A04490D84
P2860
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@ast
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@en
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@nl
type
label
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@ast
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@en
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@nl
prefLabel
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@ast
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@en
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@nl
P1476
Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
@en
P2093
Jeffrey A Kraut
P304
P356
10.1053/J.AJKD.2005.03.003
P577
2005-06-01T00:00:00Z